Adrenomedullin gene delivery reduces testicular Interstitial fibrosis via activation of the GSK-3β/β-catenin/TCF-4 signaling pathway
{{output}}
This study was designed to assess whether adrenomedullin (ADM) can alleviate testicular interstitial fibrosis by triggering the GSK-3β/β-catenin/TCF-4 cascade, consequently reducing the levels of connective tissue growth factor (CTGF), fibronectin, and type ... ...
